ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 5 filers reported holding ATARA BIOTHERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $82,621 | +45.0% | 119,051 | +7.1% | 0.00% | +33.3% |
| Q4 2023 | $56,986 | -77.2% | 111,128 | -34.2% | 0.00% | -81.2% |
| Q3 2023 | $249,996 | +86704.2% | 168,916 | -5.7% | 0.02% | -5.9% |
| Q2 2023 | $288 | -63.1% | 179,137 | -33.4% | 0.02% | -64.6% |
| Q1 2023 | $781 | -14.1% | 269,146 | -2.9% | 0.05% | -14.3% |
| Q4 2022 | $909 | -99.9% | 277,201 | +12.5% | 0.06% | -8.2% |
| Q3 2022 | $931,000 | -47.7% | 246,383 | +7.8% | 0.06% | -44.5% |
| Q2 2022 | $1,780,000 | +22.4% | 228,532 | +46.0% | 0.11% | +42.9% |
| Q1 2022 | $1,454,000 | -26.5% | 156,559 | +24.7% | 0.08% | -20.6% |
| Q4 2021 | $1,978,000 | +46.4% | 125,511 | +66.3% | 0.10% | +36.6% |
| Q3 2021 | $1,351,000 | +75.0% | 75,459 | +52.0% | 0.07% | +73.2% |
| Q2 2021 | $772,000 | +110.9% | 49,631 | +95.0% | 0.04% | +86.4% |
| Q1 2021 | $366,000 | – | 25,454 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,275,765 | $43,308,000 | 4.43% |
| RTW INVESTMENTS, LP | 473,126 | $9,004,000 | 3.27% |
| Baupost Group | 5,359,632 | $101,994,000 | 1.47% |
| 12 West Capital Management LP | 398,700 | $7,587,000 | 1.05% |
| BRIDGER MANAGEMENT, LLC | 739,444 | $14,072,000 | 0.97% |
| Cormorant Asset Management, LP | 150,000 | $2,855,000 | 0.43% |
| ArrowMark Colorado Holdings LLC | 850,040 | $16,176,000 | 0.36% |
| Virtus ETF Advisers LLC | 11,431 | $218,000 | 0.30% |
| Visium Asset Management, LP | 606,221 | $11,536,000 | 0.20% |
| EAGLE ASSET MANAGEMENT INC | 1,025,988 | $19,524,000 | 0.14% |